![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](wk6021contents.gif)
Acta Cryst. (2004). E60, o1694-o1696 [ doi:10.1107/S1600536804021233 ]
Abstract: The title compound hydroxyethylammonium enrofloxacinate [systematic name: 2-hydroxyethanaminium 1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylate], C2H8NO+·C19H21FN3O3-, contains enrofloxacinate anions and 2-hydroxyethanaminium cations. The quinoline ring system in the anions is essentially planar. The piperazine moiety adopts a chair conformation. The cations lie parallel to each other about inversion centers. The structure is stabilized by strong intermolecular hydrogen bonds involving the carbonyl, carboxyl and terminal piperazine N groups of the anion and the hydroxyl and ammonium groups of the cation.
Online 11 September 2004
Copyright © International Union of Crystallography
IUCr Webmaster